Changing face of General Practitioner in India
Over the past 65 years, several influencing factors have brought about a change in the in-clinic behaviour of the Great Indian General Practitioner. Brandcare captures how age influences physicians’ in-clinic behaviour.
This research remains highly relevant for every HCP communication agency in India — because the generational divide among physicians directly impacts how pharma brands should craft their messaging, choose their communication formats, and time their engagements across different doctor segments.
FAQ
How is the role of the Indian GP evolving?
It is changing rapidly. General practitioners in India today are typically more seasoned and operate in a completely transformed workspace compared to twenty years ago. They face higher patient expectations, new digital clinic tools, and fierce competition from specialists. To survive and thrive in this shifting landscape, the modern GP is continuously evolving alongside their daily practice.
What does this evolution mean for pharma HCP marketing strategy?
It means a single, blanket approach to GP communication simply no longer works. Because these doctors are evolving differently, a 35-year-old GP in a tier-two town and a 58-year-old GP in a metro are running completely different practices with entirely different needs. Pharma brands that fail to segment their GP universe by age and practice behavior are missing the mark and leaving a lot on the table.
Why should pharma brands care about generational differences among GPs?
Because the same message lands very differently depending on who is receiving it. A detail that resonates with a newly minted GP building his practice from scratch may feel entirely irrelevant to a veteran who has been prescribing the same molecules for thirty years. Understanding that difference is the starting point for communication that actually works.
What factors have changed in-clinic GP behaviour over the decades?
Several things have converged. Patient health awareness has gone up. Digital access has brought clinical information into the clinic in real time. Specialist referrals have become easier and more common. And the sheer volume of pharmaceutical communication has made doctors more selective about what they engage with. The clinic of today looks very little like it did in 1980.
Is the Indian GP still a relevant target for pharma brands?
Very much so. Despite the rise of specialists and corporate hospitals, the GP remains the first point of contact for a large majority of Indian patients, especially in tier two and tier three towns. That access and trust is something no specialist can replicate at scale. For pharma brands, the GP is still a very important relationship to nurture.